Compare ACM Research Inc (ACMR) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACM Research Inc vs Neurocrine Biosciences Inc — how do they compare? ACM Research Inc trades at $81.7 (market cap $5.57B), while Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 3× ACM Research Inc's market cap. Which is the better fit depends on your goals.
| ACMR | NBIX | |
|---|---|---|
Market Cap | $5.57B | $16.46B |
Sector | Technology | Health |
52-Week High | $126.89 | $185.50 |
52-Week Low | $24.93 | $123.10 |
Enterprise Value | $4.48B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACM Research Inc
ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.
Read more on ACMR →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
